Online citations, reference lists, and bibliographies.
← Back to Search

Influence Of The Surface Properties On Nanoparticle-mediated Transport Of Drugs To The Brain.

J. Kreuter
Published 2004 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Poly(alkyl cyanoacrylate) nanoparticles enable the delivery of a number of drugs, including doxorubicin, loperamide, tubocurarine, the NMDA receptor antagonist MRZ 2/576, and the peptides dalargin and kytorphin across the blood-brain barrier (BBB) after coating with surfactants. However, only the surfactants polysorbate (Tween) 20, 40, 60 and 80, and some poloxamers (Pluronic F 68) can induce this uptake. The mechanism for the delivery across the BBB most likely is endocytosis via the LDL receptor by the endothelial cells lining the brain blood capillaries after injection of the nanoparticles into the blood stream. This endocytotic uptake seems to be mediated by the adsorption of apolipoprotein B and/or E adsorption from the blood. Thus, the nanoparticles could mimic lipoprotein particles and act as "Trojan Horses." The drug, then, may be released either within these cells followed by passive diffusion into the brain or be transported into the brain by transcytosis.



This paper is referenced by
10.18632/ONCOTARGET.937
Drug-Loaded Nanoparticle Systems And Adult Stem Cells: A Potential Marriage For The Treatment Of Malignant Glioma?
B. Auffinger (2013)
10.2217/nnm.10.74
Improving the brain delivery of gold nanoparticles by conjugation with an amphipathic peptide.
S. Guerrero (2010)
Design, Characterization and Evaluation of Polymeric and Solid Lipid Nanoparticulate Systems of Olanzapine for Enhanced Efficacy
R. N. Saha (2016)
10.1016/j.jconrel.2012.04.009
Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery".
E. Mahon (2012)
10.1016/B978-0-12-809199-9.00012-4
Chapter 12 – Neurological System
Myrtill Simkó (2017)
10.5455/BCP.20120621044747
Nanotechnology Applications in Neuroscience: Advances, Opportunities and Challenges
Mesut Çetin (2012)
10.1189/jlb.0205074
Nanotechnology for the biologist
S. Mcneil (2005)
10.1002/9783527610419.NTLS0122
Nanoparticles for the Treatment of Alzheimer's Disease: Theoretical Rationale, Present Status and Future Perspectives
Gang Liu (2007)
10.1016/B978-0-444-62614-1.00019-3
Colloidal drug delivery system for brain-targeting therapy
Yung-Chih Kuo (2014)
Biophysicochemical Characteristics & Applications of Nanoparticles: Mini Review
Ankita Mahakalkar (2014)
10.1186/1743-8977-7-2
Deposition and biokinetics of inhaled nanoparticles
M. Geiser (2009)
10.18433/J3SW2T
Preparation and Physicochemical Characterization of Eudragit ® RL100 Nanosuspension with potential for Ocular Delivery of Sulfacetamide
Bivash Mandal (2010)
10.1101/871186
A Nanomule Peptide-siRNA Conjugate that Traverses the Intact Blood Brain Barrier and Attenuates Stroke
Brett Alexander Eyford (2019)
10.1523/JNEUROSCI.5731-12.2013
The Membrane-Active Tri-Block Copolymer Pluronic F-68 Profoundly Rescues Rat Hippocampal Neurons from Oxygen–Glucose Deprivation-Induced Death through Early Inhibition of Apoptosis
P. Shelat (2013)
10.1155/2017/9363040
Natural Bioactive Compounds: Alternative Approach to the Treatment of Glioblastoma Multiforme
Vilas Desai (2017)
10.1016/j.etap.2018.07.014
Altered formation of the iron oxide nanoparticle-biocorona due to individual variability and exercise.
Lisa M. Kobos (2018)
10.1080/10717544.2017.1413447
Development of novel bioadhesive granisetron hydrochloride spanlastic gel and insert for brain targeting and study their effects on rats
Rehab Abdelmonem (2018)
10.1016/j.ijpharm.2018.02.010
DoE based Olanzapine loaded poly-caprolactone nanoparticles decreases extrapyramidal effects in rodent model.
Emil Joseph (2018)
10.3390/pharmaceutics5010036
Protein Adsorption Patterns and Analysis on IV Nanoemulsions—The Key Factor Determining the Organ Distribution
Cornelia Margarete Keck (2012)
10.1002/9783527610419.NTLS0060
Conventional Chemotherapeutic Drug Nanoparticles for Cancer Treatment
L. Serpe (2007)
10.1186/1477-3155-2-3
Applications of nanoparticles in biology and medicine
OV Salata (2004)
10.1016/j.ejps.2011.12.015
Multivariate design for the evaluation of lipid and surfactant composition effect for optimisation of lipid nanoparticles.
S. Martins (2012)
10.1016/j.bcp.2017.07.008
MicroRNA: Basic concepts and implications for regeneration and repair of neurodegenerative diseases
Cláudia Saraiva (2017)
10.1243/09544062JMES1563
A gaze into the crystal ball: Biomimetics in the year 2059
I. Gebeshuber (2009)
Advances in Brain Targeted Drug Delivery: Nanoparticulate Systems
E. Joseph (2013)
10.25777/0729-JQ26
Role of Surface Chemistry in Nanoscale Electrokinetic Transport
S. Atalay (2014)
10.1553/ITA-NT-021EN
Are there any neurological effects and risks from nanoparticles to expect
M. Simkó (2011)
10.1080/09205063.2012.727378
Design and physicochemical characterization of poly(amidoamine) nanoparticles and the toxicological evaluation in human endothelial cells: applications to peptide delivery to the brain
Grégory Coué (2013)
10.1017/S1431927606060284
Phagocytosis of PLGA microparticles in rat peritoneal exudate cells: a time-dependent study.
Anderson de Jesus Gomes (2006)
10.1146/annurev.pharmtox.47.120505.105237
Drug targeting to the brain.
A. G. de Boer (2007)
10.1016/J.COLSURFB.2007.09.018
Poly(alkylcyanoacrylate) colloidal particles as vehicles for antitumour drug delivery: a comparative study.
J. Arias (2008)
10.1201/B10846-10
Transmucosal and Ocular Drug Delivery
Vasant V. Ranade (2011)
See more
Semantic Scholar Logo Some data provided by SemanticScholar